论文部分内容阅读
目的:观察血塞通注射液联合低分子肝素治疗不稳定型心绞痛的疗效及安全性。方法入选不稳定型心绞痛(UA)患者99例,随机分为血塞通组48例和对照组51例。观察两组治疗后近期及远期心绞痛的发生频率、程度、心电图改变及再住院率和转化为稳定型心绞痛的几率。结果血塞通组心绞痛发作的次数、缩短发作持续时间、减轻发作程度明显减少,S-T段下移的幅度明显降低,减少心绞痛发作时伴随的室性早搏、心动过速以及再住院的几率等,显示明显优于对照组。结论血塞通注射液联合低分子肝素治疗不稳定型心绞痛安全、有效。
Objective: To observe the efficacy and safety of Xuesaitong injection combined with low molecular weight heparin in the treatment of unstable angina pectoris. Methods A total of 99 patients with unstable angina pectoris (UA) were randomly divided into Xuesaitong group (48 cases) and control group (51 cases). The frequency, degree, electrocardiogram changes, rehospitalization rate and the probability of conversion to stable angina pectoris in both groups were observed after treatment. Results The number of episodes of angina pectoris in Xuesaitong group shortened the duration of attack and the severity of the episodes. The extent of ST segment depression was significantly reduced, and the incidence of ventricular premature beats, tachycardia and rehospitalization in angina pectoris were reduced. Showed significantly better than the control group. Conclusion Xuesaitong injection combined with low molecular weight heparin in the treatment of unstable angina pectoris is safe and effective.